From October 1, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 274,732 shares, representing 0.81% for KRW 2,997.69 million under the buyback announced on July 5, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,880 KRW | -1.18% | -5.62% | -33.03% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.03% | 144M | |
+18.39% | 125B | |
+15.38% | 108B | |
-6.71% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-13.51% | 16.34B | |
+0.35% | 13.56B | |
+24.36% | 11.59B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on July 5, 2022.